Man Claims: GlaxoSmithKline’s Parkinson’s Drug Turned Me Into a Gay Internet Sex Addict

Didier Jambart, a married father of two, is suing British pharmaceutical giant GlaxoSmithKline for making him a gay sex and gambling addict. How’s that again?

After taking the drug Requip since 2003 to treat his Parkinson’s disease, Jambart says the pills created a craving to gamble and sleep with men compulsively. The box never listed that as a side effect! Jambart, a 51-year-old French man, filed suit for $610,000, claiming GSK is responsible for his unrelenting desire to cross-dress, cruise the Internet, and put him in a situation where another man raped him. Those “symptoms” stopped in 2005, the same time he quit using the drug, but not after he lost his government job. (He’s also suing his neurologist.)

I am by no means qualified to speculate what GSK’s drugs are capable of, but if the drug maker was smart it would pay the six-figure settlement, and then invest eight figures into R&D to figure out how to turn Requip into the new Viagra. In the meantime, Jambart should look into this product:

Get Queerty Daily

Subscribe to Queerty for a daily dose of #didierjambart #drugs #glaxosmithkline stories and more


  • Daveny

    Sounds like someone got caught doing something by his wife that he couldn’t talk his way out of. lol

  • scribe

    There is a list of dudes I want to start taking this.

  • greenmanTN

    Does GlaxoSmithKline also make communion wafers for the US Christian Right? It would certainly explain a lot!

  • greenmanTN

    @Kev C: Very interesting! Hypersexuality might be a side effect but presumably the homosexual component of his “acting out” was part of his sexual makeup to begin with. It could be argued, I guess, that gay men are much more available than women (other than prostitutes) to satisfy hypersexual urges with so he was driven to men as sexual partners.

  • Kev C

    It can be argued if the drug turns some “gay” but obsessively hypersexual like Bonobo chimps. Bisexual or omnisexual sex-crazed super sluts (non-scientific term).

  • Elias Meeks

    Not so fast with the schadenfreude! Both Requip and its nasty cousin Mirapex have a long trail of victims who got their psychological insides turned outside by that stuff and I happen to be one of them. It is true that if a person on those particular Dopamine Agonists acts out in a certain way that the tendency to do so was probably already there to begin with. This is probably why after taking the stuff for more than 6 months I ended up out of the closet and eventually divorced. The body’s naturally-produced Dopamine makes the body feel good under stress. Any distance-runner can describe the “high” it gives them during marathons. At the same time, if you ratchet up your Dopamine levels several notches with a pharmaceutical additive, pretty soon you are feeling good about everything you do and doing it without fear or guilt! Sex and gambling benders by Requip-medicated Parkinson’s patients are just a couple of examples of the bizarre behavioral side-effects associated with the drug.

    Still, the commenter who suggested making communion wafers out of the stuff has a valid point: after observing my erratic behavioral response to Requip over time a friend finally dubbed it “the cure for Christianity.”

  • thematics

    I’ve also seen people on dopamine agonists engage in wild shopping spreees totaling many many thousands of dollars they could ill afford. Sometimes they are wronly labeled as bipolar (manic depressive) until it’s clear what class of drugs they’re on. ~~That’s why you should carry a list of your meds in your wallet/purse/totebag, etc.~~

    Becoming hypersexual due to meds doesn’t change one’s sexual orientation (that I’ve heard of, at least) so I’d very much suspect the French guy had same-sex attraction prior to starting on the drugs. Now, he’ll be marching in the Paris Pride shaking his bonbon with the best of them!

  • Robbie K

    What about us who are gay internet sex addicts now..I say damn that vitamin C.

Comments are closed.